| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/04/2023 | ATOSSA THERAPEUTICS, INC. | ATOS | Grant | Stock Option (right to buy) | 125k | $0.66 | $82.8k | | 05/04/2023 |
| 05/13/2022 | ATOSSA THERAPEUTICS, INC. | ATOS | Grant | Stock Option (right to buy) | 50k | $0.93 | $46.5k | | 05/13/2022 |
| 03/02/2022 | ATAI Life Sciences N.V. | | Grant | Stock Option | 228k | $5.65 | $1.3M | | 03/02/2022 |
| 07/02/2021 | ATOSSA THERAPEUTICS, INC. | ATOS | Payment of Exercise | Common Stock | 57.1k | $6.40 | $365.3k | | 07/02/2021 |
| 07/02/2021 | ATOSSA THERAPEUTICS, INC. | ATOS | Sale | Common Stock | 107.5k | $5.58 | $599.8k | | 07/02/2021 |
| 07/02/2021 | ATOSSA THERAPEUTICS, INC. | ATOS | Exercise | Stock Option (right to buy) | 4.6k | $5.64 | $25.8k | | 07/02/2021 |
| 07/02/2021 | ATOSSA THERAPEUTICS, INC. | ATOS | Exercise | Stock Option (right to buy) | 45k | $2.38 | $107.1k | | 07/02/2021 |
| 07/02/2021 | ATOSSA THERAPEUTICS, INC. | ATOS | Exercise | Stock Option (right to buy) | 45k | $2.52 | $113.4k | | 07/02/2021 |
| 07/02/2021 | ATOSSA THERAPEUTICS, INC. | ATOS | Exercise | Stock Option (right to buy) | 70k | $1.70 | $119k | | 07/02/2021 |
| 06/22/2021 | ATAI Life Sciences N.V. | | Purchase | Common Shares | 4.7k | $15.00 | $70k | | 06/22/2021 |
| 06/17/2021 | ATAI Life Sciences N.V. | | Grant | Stock Option | 67.7k | $15.00 | $1M | | 06/17/2021 |
| 05/14/2021 | ATOSSA THERAPEUTICS, INC. | ATOS | Grant | Stock Option (right to buy) | 50k | $2.90 | $145k | | 05/14/2021 |
| 05/15/2020 | ATOSSA THERAPEUTICS, INC. | ATOS | Grant | Stock Option (right to buy) | 70k | $1.70 | $119k | | 05/15/2020 |
| 03/15/2020 | Eloxx Pharmaceuticals, Inc. | ELOX | Payment of Exercise | Common Stock | 1.1k | $2.85 | $3.1k | | 03/15/2020 |
| 03/15/2020 | Eloxx Pharmaceuticals, Inc. | ELOX | Exercise | Restricted Stock Units | 3.8k | $0.00 | $0 | | 03/15/2020 |
| 01/30/2020 | Eloxx Pharmaceuticals, Inc. | ELOX | Payment of Exercise | Common Stock | 1.7k | $3.91 | $6.8k | | 01/30/2020 |
| 01/30/2020 | Eloxx Pharmaceuticals, Inc. | ELOX | Exercise | Restricted Stock Units | 5k | $0.00 | $0 | | 01/30/2020 |
| 01/30/2020 | Eloxx Pharmaceuticals, Inc. | ELOX | Payment of Exercise | Common Stock | 1.7k | $3.91 | $6.8k | | 01/30/2020 |
| 01/30/2020 | Eloxx Pharmaceuticals, Inc. | ELOX | Exercise | Restricted Stock Units | 5k | $0.00 | $0 | | 01/30/2020 |
| 05/17/2019 | ATOSSA THERAPEUTICS, INC. | ATOS | Grant | Stock Option (right to buy) | 45k | $2.52 | $113.4k | | 05/17/2019 |
| 01/31/2019 | Zyla Life Sciences | ZCOR | Disposition | Stock Option (Right to Buy) | 75k | $0.60 | $45k | | 01/31/2019 |
| 01/31/2019 | Zyla Life Sciences | ZCOR | Disposition | Stock Option (Right to Buy) | 58.1k | $2.38 | $138.4k | | 01/31/2019 |
| 01/31/2019 | Zyla Life Sciences | ZCOR | Disposition | Stock Option (Right to Buy) | 29.7k | $4.98 | $147.7k | | 01/31/2019 |
| 01/31/2019 | Zyla Life Sciences | ZCOR | Disposition | Stock Option (Right to Buy) | 10k | $12.08 | $120.8k | | 01/31/2019 |
| 01/31/2019 | Zyla Life Sciences | ZCOR | Disposition | Stock Option (Right to Buy) | 20k | $5.70 | $114k | | 01/31/2019 |
| 01/31/2019 | Zyla Life Sciences | ZCOR | Disposition | Stock Option (Right to Buy) | 667 | $15.00 | $10k | | 01/31/2019 |
| 01/31/2019 | Zyla Life Sciences | ZCOR | Disposition | Stock Option (Right to Buy) | 2.1k | $12.00 | $25k | | 01/31/2019 |
| 01/30/2019 | Eloxx Pharmaceuticals, Inc. | ELOX | Grant | Stock Options | 60k | $11.53 | $691.8k | | 01/30/2019 |
| 01/30/2019 | Eloxx Pharmaceuticals, Inc. | ELOX | Grant | Restricted Stock Units | 20k | $0.00 | $0 | | 01/30/2019 |
| 06/27/2018 | ATOSSA THERAPEUTICS, INC. | ATOS | Grant | Stock Option (right to buy) | 45k | $2.38 | $107.1k | | 06/27/2018 |
| 05/14/2018 | Zyla Life Sciences | ZCOR | Grant | Stock Option (Right to Buy) | 75k | $0.60 | $45k | | 05/14/2018 |
| 03/23/2018 | Eloxx Pharmaceuticals, Inc. | ELOX | Purchase | Common Stock | 4.5k | $8.56 | $38.5k | | 03/23/2018 |
| 12/20/2017 | Eloxx Pharmaceuticals, Inc. | ELOX | Grant | Stock Option (Right to Buy) | 399.3k | $7.00 | $2.8M | | 12/20/2017 |
| 12/20/2017 | Eloxx Pharmaceuticals, Inc. | ELOX | Grant | Employee Stock Option (Right to Buy) | 399.3k | $0.00 | $0 | | 12/20/2017 |
| 06/08/2017 | Zyla Life Sciences | ZCOR | Grant | Stock Option (Right to Buy) | 58.1k | $2.38 | $138.4k | | 06/08/2017 |
|